πŸ‡ΊπŸ‡Έ FDA
Patent

US 10344271

Modified zinc finger binding proteins

granted A61KA61K48/00

Quick answer

US patent 10344271 (Modified zinc finger binding proteins) held by Sangamo Therapeutics, Inc. expires Mon Jul 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sangamo Therapeutics, Inc.
Grant date
Tue Jul 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K48/00